These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2654463)

  • 1. [Antimicrobial drugs in the treatment of stomach and duodenal diseases associated with Campylobacter pylori].
    Perederiĭ VG; Rozhavin MA
    Klin Med (Mosk); 1989 Jan; 67(1):44-8. PubMed ID: 2654463
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible pathogenetic pathways of Campylobacter pylori in gastro-duodenal disease.
    Rathbone BJ; Wyatt JI; Heatley RV
    Scand J Gastroenterol Suppl; 1988; 142():40-3. PubMed ID: 3166532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Campylobacter pylori colonization and gastroduodenal pathology].
    Gullini S; Basso O; Boccia S; Macario F; Cantarini D; Ghinelli F
    Minerva Med; 1988 Nov; 79(11):957-60. PubMed ID: 3200472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Campylobacter pyloridis--a cause of gastritis/ulcer?].
    Gustavsson S
    Lakartidningen; 1986 Aug; 83(35):2822-4. PubMed ID: 3747663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Campylobacter pyloridis--saprophyte or pathogen?].
    Rösch W
    Leber Magen Darm; 1986 Sep; 16(5):268-75. PubMed ID: 3537597
    [No Abstract]   [Full Text] [Related]  

  • 9. Methodological problems of randomized clinical trials in the treatment of duodenal ulcer, "gastritis" and Campylobacter pylori infection.
    Poynard T; Pignon JP; Mory B; Naveau S; Chaput JC
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):112B-115B. PubMed ID: 2663589
    [No Abstract]   [Full Text] [Related]  

  • 10. Campylobacter pylori and peptic ulcer therapy.
    Bianchi Porro G; Lazzaroni M
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):107B-111B. PubMed ID: 2663588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Campylobacter pylori and pathology of the gastro-duodenal mucosa. Critical review of clinico-experimental and therapeutic contributions].
    Lazzaroni M; Bianchi Porro G
    Medicina (Firenze); 1989; 9(1):9-18. PubMed ID: 2661960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Campylobacter pylori, its detection and association with common pathologic conditions of the gastro-duodenum].
    Fixa B; Komárková O; Krejsek J; Bures J; Melichar B; Dvorácek I
    Vnitr Lek; 1990 Feb; 36(2):170-6. PubMed ID: 2336815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotics for Campylobacter pylori colonization of the stomach].
    Schmidt G; Opferkuch W; Rühl G; Haase G
    Dtsch Med Wochenschr; 1989 Nov; 114(46):1812-3. PubMed ID: 2583013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gastritis and ulcer: reconsidering therapy? Report from a presymposium: "Campylobacter pylori--value of therapy today". 3 March 1989, Taormina/Sicily. Abstracts].
    Fortschr Med Suppl; 1989; 62():1-22. PubMed ID: 2737588
    [No Abstract]   [Full Text] [Related]  

  • 16. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Campylobacter pyloridis: a new pathogenetic hypothesis and new guidelines in the therapy of gastritis and peptic ulcer].
    D'Amore V; Prandi GC
    Minerva Dietol Gastroenterol; 1988; 34(1):13-9. PubMed ID: 3290723
    [No Abstract]   [Full Text] [Related]  

  • 18. [Helicobacter pylori-induced cost-benefit risk considerations].
    Leiss O
    Leber Magen Darm; 1989 Dec; 19(6):333-5. PubMed ID: 2575693
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pyloric Campylobacter and esophago-gastroduodenal pathology].
    León-Barua R
    Acta Gastroenterol Latinoam; 1985; 15(2):129-31. PubMed ID: 3835764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Campylobacter pyloridis and gastroduodenal pathology].
    Thomas CM; Rosenau A; Tulliez M; Paul G; Gaudric M; Neuman M; Guerre J
    Ann Med Interne (Paris); 1987; 138(6):403-6. PubMed ID: 3434925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.